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Aortic stenosis (AS) is the most common valvular heart disease in
western countries [1]. Recent series reported that early surgery, i.e.
aortic valve replacement (AVR) in asymptomatic patients and preserved
left ventricular (LV) function, was associated with improved clinical
outcomes [2,3]. Although AVR is safe andwidely performed, the rates of
both operative mortality and valve-related complications cannot be
overlooked. The risk–beneﬁt ratio of early strategy should be carefully
evaluated and the decision-making could be reﬁned by quantitative and
reliable parameters. In this regard, the recently updated ESC guidelines
suggest the usefulness of B-type natriuretic peptide (BNP) level
measurement [4]. The aim of this study was to identify resting and
exercise echocardiographic determinants of BNP level in asymptomatic
patients with AS and preserved LV function.
We prospectively included 61 asymptomatic patients with at least
moderate AS (aortic valve area b1.5 cm2) and preserved LV ejection
fraction (N50%) that were referred to our Heart Valve Clinic to perform
resting and exercise Doppler echocardiography with concomitant BNP
level measurement. The study protocol conforms to the ethical
guidelines of the 1975 Declaration of Helsinki as reﬂected in a priori
approval by the institution's human research committee and all
patients gave written informed consent.
Patients were divided into 2 groups according to BNP level
median (66 pg/mL). All patients presented at least a moderate AS
(1.0 ± 0.3 cm2; range: 0.4–1.5 cm2) and preserved LV ejection fraction
(69 ± 7%; range: 55–81%). Mean age of the population was 70 ± 13
(range: 31–87) years old and a signiﬁcant correlation between age
and BNP levels was found (r = 0.40; p = 0.001). The distribution of
BNP levels was 104 ± 142 pg/mL; median: 66; range: 5–700 pg/mL.
Patients in the high BNP level group were signiﬁcantly older
(p b 0.001), more often in atrial ﬁbrillation (p b 0.001) or with
hypertension (p= 0.048). There were no other signiﬁcant differences
regarding clinical characteristics.
Patients in the high BNP level grouphad signiﬁcant higher indexed left
atrial area (p= 0.017) andE/e′ ratio (p= 0.001). Therewasno signiﬁcant
difference in AS severity and LV mass, volumes and function between
groups (Table 1). Signiﬁcant correlations were found between BNP levels
and indexed left atrial area (r = 0.346; p= 0.008), E/A ratio (r = 0.344;
p= 0.009) and E/e′ ratio (r = 0.584; p b 0.001, Fig.1b). After adjustment
for age, indexed aortic valve area, LV global longitudinal strain and left
atrial area, multivariable analysis identiﬁed E/e′ (β= 18.2 ± 2.9;
p b 0.001) and LV end-diastolic volume (β=−2.1 ± 0.7; p= 0.006) as
independent resting predictors of BNP level.
Patients in the high BNP level group had signiﬁcant higher exercise
E/e′ ratio (p = 0.018) and lower LV global longitudinal strain
(p = 0.020). There was no difference in AS severity, LV stroke volume
and ejection fraction between groups (Table 1). Signiﬁcant correla-
tions were found between BNP levels and exercise indexed aortic
valve area (r =−0.324; p = 0.028), E/e′ ratio (r = 0.543; p b 0.001;
Fig. 1c) and LV global longitudinal strain (r =−0.491; p = 0.002;
Fig. 1d). After adjustment for age and indexed aortic valve area,
multivariable analysis identiﬁed E/e′ (β= 14.4 ± 5.6; p = 0.015) and
LV global longitudinal strain (β=−9.7 ± 3.6; p = 0.011) as inde-
pendent exercise determinants of BNP level.
This study shows that, in asymptomatic patients with preserved
LV function and at least moderate AS, the BNP level is determined
by LV end-diastolic volume, both resting and exercise estimated LV
ﬁlling pressure and exercise LV global longitudinal strain, suggesting
the presence of both subclinical LV diastolic and systolic dysfunction.
In the natural history of AS, the chronic increase in afterload is
compensated by LV remodeling and concentric hypertrophy main-
taining patients free of symptoms. However, at a later stage, LV
hypertrophy may be no longer sufﬁcient to compensate the afterload
and increase in LV wall stress and ﬁlling pressure may occur resulting
in symptoms and poor outcome. The E/e′ ratio is recognized as a
noninvasive measurement of LV ﬁlling pressure in patients with AS
[5,6] and the BNP activation is known to be a good surrogate marker of
the occurrence of symptoms [6,7]. Consistently, our results have
shown that the main determinant of BNP level is the estimated LV
ﬁling pressure using E/e′ ratio. In a cohort of 135 patients with AS,
several indices of LV diastolic functionwere associated with BNP level,
such as the E/A ratio, the E/e′ ratio and the left atrial area, regardless of
the symptomatic status [8]. Those data are concordant with our
ﬁndings. However, to the best of our knowledge, we are the ﬁrst to
validate those parameters as independent determinants of BNP level
in a cohort of “truly” asymptomatic patients with AS and preserved LV
function.
Even in patients with severe AS, LV ejection fraction may remain
normal during a long time. However, LV global longitudinal strain has
been shown to reveal intrinsic myocardial dysfunction in those
patients. In fact, a decrease in global longitudinal strain was superior
to standard LV ejection fraction measurement in predicting symp-
toms, exercise tolerance and outcome [9,10]. In the presence of severe
AS, the afterload mismatch and the increase in LV ﬁlling pressure may
dramatically limit the recruitment of longitudinal myocardial reserve
during exercise. Very few data are available relative to exercise-
induced changes in LV longitudinal function and none have evaluated
their association with BNP release. In our study, we have demon-
strated that exercise global longitudinal strain was independently
associated with BNP level.
Compared to previous studies, AS severity parameters did not
emerge as independent predictors of BNP level and those correlations
were probably weakened by the analysis of more powerful predictors.
Also, indexed LV mass was not signiﬁcantly related to BNP level. This
illustrates that LV afterload rather than the amount of LV hypertrophy
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Table 1
Echocardiographic data according to BNP level.
Whole cohort n = 61 Low BNP group n = 32, 52% High BNP group n = 29, 48% p-Value
Resting parameters
AS severity
Peak velocity, m/s 3.7 ± 0.7 3.6 ± 0.5 3.8 ± 0.8 0.369
Mean pressure gradient, mm Hg 37 ± 14 34 ± 10 40 ± 17 0.130
Indexed valve area, cm2/m2 0.53 ± 0.13 0.55 ± 0.11 0.52 ± 0.16 0.350
LV geometry and function
Indexed mass, g/m2 88 ± 26 83 ± 26 93 ± 24 0.146
Indexed end-diastolic volume, mL/m2 44 ± 12 46 ± 14 42 ± 9 0.286
Indexed end-systolic volume, mL/m2 14 ± 6 15 ± 7 13 ± 4 0.139
Indexed stroke volume, mL/m2 45 ± 9 44 ± 8 46 ± 10 0.536
Ejection fraction, % 69 ± 7 68 ± 6 70 ± 7 0.246
E/A ratio 0.90 ± 0.35 0.84 ± 0.30 0.97 ± 0.40 0.185
E/e′ ratio 11 ± 4 9 ± 3 13 ± 5 0.001
Global longitudinal strain, % −20 ± 3 −20 ± 3 −19 ± 3 0.200
Indexed left atrial area, cm2/m2 9.6 ± 2.4 8.9 ± 2.1 10.4 ± 2.6 0. 017
Exercise parameters
AS severity
Peak velocity, m/s 4.2 ± 0.8 4.1 ± 0.6 4.2 ± 0.9 0.620
Mean pressure gradient, mm Hg 48 ± 20 44 ± 16 52 ± 25 0.167
Indexed valve area, cm2/m2 0.57 ± 0.13 0.58 ± 0.11 0.55 ± 0.15 0.324
LV geometry and function
Indexed stroke volume, mL/m2 48 ± 12 46 ± 9 50 ± 15 0.221
Ejection fraction, % 72 ± 6 73 ± 5 72 ± 7 0.883
E/e′ ratio 12 ± 4 11 ± 3 14 ± 5 0.018
Global longitudinal strain, % −21 ± 3 −23 ± 3 −20 ± 3 0.020
AS indicates aortic stenosis and LV indicates left ventricular.
Fig. 1. Relationship between resting LV end-diastolic volume (panel a), resting E/e′ ratio (panel b), exercise E/e′ ratio (panel c), exercise LV global longitudinal strain (panel d) and
BNP level.
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may contribute: (1) to the elevation of LV wall stress and ﬁlling
pressure, and (2) to the impairment of the LV longitudinal function by
reducing coronary ﬂow reserve.
In asymptomatic patients with moderate to severe AS and
preserved LV ejection fraction, BNP release is mainly determined by
LV end-diastolic volume, LV ﬁlling pressure estimation (diastolic
burden) and exercise LV longitudinal strain (subclinical LV dysfunc-
tion). Further studies are needed to clarify the role of those
determinants in risk stratiﬁcation of asymptomatic patients with AS.
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It has been suggested that atherosclerosis involves cross talk
between innate and adaptive immunity [1]. Natural killer (NK) cells
principally contribute to innate immunity and adaptive immune
responses by killing target cells or by prompting the productions of
various cytokines and chemokines [2]. Due to these properties, NK
cells play signiﬁcant roles in the control of microbial infections [3].
Several human studies have shown that NK cell activity is depressed in
patients with coronary artery disease (CAD) [4,5]. However, the
mechanism of NK cell dysfunction in CAD remains unclear. The core of
toxic granules in NK cells is surrounded by a lipid bilayer that contains
Fas ligand and LAMPs [6]. As degranulation occurs, secretory
lysosomes are released, and LAMP-1 (known as CD107a) is trans-
ported to the cellular surface. Thus, the cell surface expression of
lysosomal-associated membrane protein-1 (LAMP-1 or CD107a) has
been described as a sensitive marker for NK cell degranulation and
cytotoxicity [7]. Accordingly, the aim of this study was to evaluate NK
cell level and function in CAD, and to investigate changes in NK cell
degranulation.
The study cohort included 59 healthy controls (HCs), 66 patients
with chronic stable angina (CSA), and 121 patients with acute
coronary syndrome (ACS). The subjects with no symptoms of CAD
and with normal routine laboratory test results were enrolled as a
healthy control group. However, no coronary angiogram was
performed in the control group. NK cells were identiﬁed phenotypi-
cally as CD3-CD45+CD56+ cells by ﬂow cytometry [8]. Circulating
NK cell numbers and cytotoxicities of peripheral blood mononuclear
cells (PBMCs) and NK cells against K562 cells were assayed by ﬂow
cytometry as previously described [8]. The degranulation of NK cells in
response to K562 cells was determined by ﬂow cytometry as
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